Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.6435.7730.8923.5130.67

What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 25.64 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.64
Mar202535.77
Mar202430.89
Mar202323.51
Mar202230.67

How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 25.64
-28.32
Mar2025 35.77
15.80
Mar2024 30.89
31.39
Mar2023 23.51
-23.35
Mar2022 30.67 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,518.2 Cr 2.2% 11% -25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,924.0 Cr -0.3% 3.4% 12.7% Stock Analytics
DIVIS LABORATORIES ₹174,619.0 Cr -2.5% -1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹156,450.0 Cr 2.4% 5.2% 47.2% Stock Analytics
CIPLA ₹118,361.0 Cr 2.2% 4.8% -3% Stock Analytics
DR REDDYS LABORATORIES ₹113,253.0 Cr 4.3% 4.1% 4.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

2.2%

11%

-25.7%

SENSEX

-0.8%

0.8%

-7.2%


You may also like the below Video Courses